Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
diagnosis
|
| gptkbp:analyzes |
solid tumors
|
| gptkbp:approvalYear |
2017
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:detects |
biomarkers
genomic alterations microsatellite instability tumor mutational burden |
| gptkbp:developedBy |
gptkb:Foundation_Medicine
|
| gptkbp:enables |
targeted therapy selection
|
| https://www.w3.org/2000/01/rdf-schema#label |
FoundationOne CDx
|
| gptkbp:marketedAs |
gptkb:Foundation_Medicine
|
| gptkbp:provides |
comprehensive genomic profiling
|
| gptkbp:regulates |
FDA-approved
|
| gptkbp:size |
324 genes
|
| gptkbp:type |
next-generation sequencing
formalin-fixed paraffin-embedded tissue |
| gptkbp:usedFor |
cancer diagnosis
companion diagnostic |
| gptkbp:website |
https://www.foundationmedicine.com/tests/foundation-one-cdx
|
| gptkbp:bfsParent |
gptkb:Foundation_Medicine
|
| gptkbp:bfsLayer |
6
|